Equivalence test in quantitative reverse transcription polymerase chain reaction: confirmation of reference genes...

Area of Science:

• Molecular Biology
• Genomics
• Biostatistics

Background:

• Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) relies on reference genes for accurate gene expression normalization.
• The selection and validation of appropriate reference genes are critical but often problematic.
• Using unvalidated reference genes can lead to misinterpretation of target gene expression data.

Purpose of the Study:

• To develop and evaluate a statistical approach for identifying and validating stably expressed reference genes for qRT-PCR.
• To introduce the equivalence test as a method for reference gene validation.
• To assess the suitability of commonly used reference genes across different cancer types and experimental conditions.

Main Methods:

• Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was performed on multiple tumor tissue types.
• The expression stability of five candidate reference genes (18S, B2M, HPRT1, LMNB1, SDHA) and two target genes (TP53, MMP2) was analyzed.
• An equivalence test was employed to identify stably expressed reference genes.

Main Results:

• Reference gene stability was not consistent across different tumor types (clear cell renal cell carcinoma, colon carcinoma, gastrointestinal stromal tumors).
• Even within a single tumor type, reference gene expression stability varied depending on the biological comparisons being made.
• The study identified significant variability in the expression of commonly used reference genes.

Conclusions:

• There is no universal reference gene applicable to all qRT-PCR experiments.
• Specific validation of reference genes is essential for each experimental condition and biological context.
• The equivalence test provides a robust statistical method for reference gene validation in qRT-PCR assays.